Therefore, in CRC data using both tumor tissues from patients and stool DNA, TFPI2 has been strongly suggested as a potential biomarker for noninvasive detection of colorectal neoplasia [51]. This evidence concerns the gene TFPI2 and colorectal carcinoma.